首页 | 本学科首页   官方微博 | 高级检索  
检索        


PCN13 Quality-of-Life (QOL) Results from the Phase 3 Rainbow-ASIA Study of Ramucirumab PLUS paclitaxel (RAM/PTX) Versus Placebo PLUS paclitaxel (PBO/PTX) in Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (AGC)
Authors:R Xu  L Shen  Y Qin  S Qin  X Yin  B Liu  S Tanasanvimon  C Zhou  W Zhang  L Zhou
Institution:1. Sun Yat-sen University Cancer Center, Guangzhou, China;2. Peking University Cancer Hospital & Institute, Beijing, China;3. The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;4. Cancer Center of Nanjing Bayi Hospital, Nanjing Chinese Medicine University, Nanjing, China;5. Hunan Cancer Hospital, Changsha, China;6. Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China;7. King Chulalongkorn Memorial Hospital, Bangkok, Thailand;8. Eli Lilly and Company, Shanghai, China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号